AI assistant
Sending…
Rezolute, Inc. — Director's Dealing 2015
Jun 29, 2015
32362_dirs_2015-06-29_ebe835db-a036-40b6-8f60-40964ac0dfc5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AntriaBio, Inc. (ANTB)
CIK: 0001509261
Period of Report: 2015-06-24
Reporting Person: Welch David F (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1766432 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant to purchase Common Stock | $1.89 | 2017-01-15 | Common Stock (8334) | Indirect | |
| Warrant to purchase Common Stock | $2.34 | 2017-03-31 | Common Stock (96155) | Indirect | |
| Warrant to purchase Common Stock | $2.50 | 2017-12-31 | Common Stock (1081082) | Indirect | |
| Warrant to purchase Common Stock | $2.50 | 2018-04-06 | Common Stock (540541) | Indirect |
Footnotes
F1: LRFA, LLC owns shares of common stock and warrants to purchase shares of common stock of the Issuer. Dr. Welch is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock held by LRFA, LLC.
More from Rezolute, Inc.
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12
Interim / Quarterly Report
2026
Feb 12
Major Shareholding Notification
2026
Jan 30
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 7
Major Shareholding Notification
2025
Dec 19